Legal & General Group’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$175K Sell
71,466
-51,161
-42% -$125K ﹤0.01% 2596
2025
Q1
$818K Buy
122,627
+47,173
+63% +$315K ﹤0.01% 2247
2024
Q4
$948K Buy
75,454
+8,267
+12% +$104K ﹤0.01% 2262
2024
Q3
$1.24M Buy
67,187
+130
+0.2% +$2.4K ﹤0.01% 2159
2024
Q2
$1.44M Buy
67,057
+860
+1% +$18.5K ﹤0.01% 2070
2024
Q1
$1.78M Sell
66,197
-243
-0.4% -$6.55K ﹤0.01% 1987
2023
Q4
$1.99M Buy
66,440
+9,283
+16% +$278K ﹤0.01% 1958
2023
Q3
$1.17M Buy
57,157
+2,719
+5% +$55.7K ﹤0.01% 2132
2023
Q2
$1.08M Buy
54,438
+605
+1% +$12K ﹤0.01% 2193
2023
Q1
$922K Buy
53,833
+13,041
+32% +$223K ﹤0.01% 2170
2022
Q4
$798K Buy
40,792
+5,217
+15% +$102K ﹤0.01% 2213
2022
Q3
$568K Sell
35,575
-3,398
-9% -$54.3K ﹤0.01% 2313
2022
Q2
$536K Buy
38,973
+9,274
+31% +$128K ﹤0.01% 2320
2022
Q1
$471K Sell
29,699
-69
-0.2% -$1.09K ﹤0.01% 2409
2021
Q4
$650K Buy
29,768
+87
+0.3% +$1.9K ﹤0.01% 2338
2021
Q3
$887K Buy
29,681
+7,566
+34% +$226K ﹤0.01% 2273
2021
Q2
$980K Buy
22,115
+373
+2% +$16.5K ﹤0.01% 2217
2021
Q1
$965K Buy
21,742
+16,700
+331% +$741K ﹤0.01% 2203
2020
Q4
$277K Buy
5,042
+198
+4% +$10.9K ﹤0.01% 2363
2020
Q3
$111K Sell
4,844
-1,509
-24% -$34.6K ﹤0.01% 2459
2020
Q2
$133K Buy
6,353
+546
+9% +$11.4K ﹤0.01% 2453
2020
Q1
$81K Sell
5,807
-1,125
-16% -$15.7K ﹤0.01% 2468
2019
Q4
$158K Buy
6,932
+1,241
+22% +$28.3K ﹤0.01% 2457
2019
Q3
$67K Hold
5,691
﹤0.01% 2648
2019
Q2
$85K Buy
5,691
+914
+19% +$13.7K ﹤0.01% 2585
2019
Q1
$84K Buy
4,777
+873
+22% +$15.4K ﹤0.01% 2543
2018
Q4
$58K Buy
3,904
+739
+23% +$11K ﹤0.01% 2637
2018
Q3
$78K Hold
3,165
﹤0.01% 2579
2018
Q2
$62K Buy
+3,165
New +$62K ﹤0.01% 2658
2017
Q2
Sell
-494
Closed -$4K 3373
2017
Q1
$4K Hold
494
﹤0.01% 3248
2016
Q4
$12K Buy
+494
New +$12K ﹤0.01% 3197